reference/33605125

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33605125

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural
endingPage	647
issn	1527-7755 0732-183X
issueIdentifier	4
pageRange	641-647
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	641
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3de99b234eaac1a6b312556d59ffa388 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b88662a17e22ebcca1707e323327d3e8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bdedda6bc8f3d7b49612bce7a2d07095 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e5757c483e93d64a2efed8f51f6c6111 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d4fffafc8d662404048172fab252862 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4d3d6cb1ae18644a6301f2f5e7a1a0ee http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0adca88b0c729097db32c74c264ae68e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_636b440257b81fc76969778dea622a4e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5db0deb7d0a3d588be9cbfe27581edfc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f92590cf8e2066a2e2e126facb3e1001 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2efad196d796aab7f3201956fbf1dada http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f9db0a009848d3b9051dfed0bcbac227 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6915584dc615683d2882680b79106e61 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6c52b197315daecc8636d6b18ec3e128 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_75f3c3c5f822ec25b8e1db4daaccdb06 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dba691968fc35a0e1b8833f688f8f07d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b9d7a641bcef91da984d8832f0ad7211 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_288d3b52e1434f2c41383491a215da02 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0f9f33acf5fddb3e56cd220efa92f3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_844eab323994738a156684e6db96eb8d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4634c243785571d8327ee65dcc1b4370 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4800e4b83f6f0e088468279522f43b32 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d31c6a0e50d6c5c5d57166acc0ce876e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9d564233b9543dd351385e715fd6a9da
bibliographicCitation	Loprinzi CL, Qin R, Balcueva EP, Baclueva EP, Flynn KA, Rowland KM, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol. 2010 Feb 01;28(4):641–7. PMID: 19901102; PMCID: PMC2815998.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d4154b4dc2a928d977a2ccb3f64b319 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_412a6988f3efda324352ae4f9b5b51ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7fcbec79c36151ea3fb4be64a47e225 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_112b951d29d0c70b5e51a433db09d9c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddfb9bbca0c30716f7de8b367ff12860 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09cf0b36ed1c4c509f86447d61012182 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f424d941e0419448dd720c1626427b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa7afc0ef45c26fd2d045966a06118f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aef97933c0c38f21b15a91e65d54543c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30fcd37f22da4258c91711962ae2efdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6b2a21ab11147c07e1691719c7aa66a
date	2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2815998 https://pubmed.ncbi.nlm.nih.gov/19901102 https://doi.org/10.1200/jco.2009.24.5647
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1
discusses	http://id.nlm.nih.gov/mesh/M0214473 http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0008927
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005680Q000031 http://id.nlm.nih.gov/mesh/D019584Q000188 http://id.nlm.nih.gov/mesh/D000927Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D017698 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000069583 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010919 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019584Q000473 http://id.nlm.nih.gov/mesh/D005680Q000627 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D011788
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10389 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486971

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127564392 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129364554 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127479071

Total number of triples: 88.